Indranil Dey, President and CEO at Bluejay Diagnostics, Inc. (BJDX), bought 12,500 shares at $2.00 ($25K) on 2026-03-14, disclosed to the SEC on 2026-05-18.
CEO Indranil Dey purchased $25,000 of stock at $2.00, signaling confidence despite the stock's steep decline. This move is notable as the shares are trading at the 52-week low, potentially offering a value entry point.
The stock has crashed 76.82% over the past year and is currently trading at the 52-week low of $1.66, down 5.14% in the last five days.
Insufficient data — needs manual review
The company trades at a negative forward P/E of -6.03, indicating potential profitability concerns, and has a short interest of 2.21%.
Clearly above the average filing.